TIMP-1 Mediates Inflammatory and Immune Response to IL-6 in Adult Orbital Xanthogranulomatous Disease

REFERENCES

• Jakobiec FA, Mills MD, Hidayat AA, et al. Periocular xanthogranulomas associated with severe adult-onset asthma. Trans Am Ophthalmol Soc. 1993;91:99–125. discussion 125-9.
   PubMedGoogle Scholar
• Sivak-Callcott JA, Rootman J, Rasmussen SL, et al. Adult xanthogranulomatous disease of the orbit and ocular adnexa: new immunohistochemical findings and clinical review. Br J Ophthalmol. 2006;90(5):602–608. doi:10.1136/bjo.2005.085894.
   PubMed Web of Science ®Google Scholar
• Hammond MD, Niemi EW, Ward TP, Eiseman AS. Adult orbital xanthogranuloma with associated adult-onset asthma. Ophthalmic Plast Reconstr Surg. 2004;20:329–332.
   PubMed Web of Science ®Google Scholar
• Kerstetter J, Wang J. Adult orbital xanthogranulomatous disease: a review with emphasis on etiology, systemic associations, diagnostic tools, and treatment. Dermatol Clin. 2015;33(3):457–463. doi:10.1016/j.det.2015.03.010.
   PubMed Web of Science ®Google Scholar
• Massova I, Kotra LP, Fridman R, Mobashery S. Matrix metalloproteinases: structures, evolution, and diversification. Faseb J. 1998;12:1075–1095.
   PubMed Web of Science ®Google Scholar
• Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol. 1997;74:111–122.
   PubMed Web of Science ®Google Scholar
• Al Shammari B, Shiomi T, Tezera L, et al. The extracellular matrix regulates granuloma necrosis in tuberculosis. J Infect Dis. 2015;212(3):463–473. doi:10.1093/infdis/jiv076.
   PubMed Web of Science ®Google Scholar
• Brew K, Nagase H. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophys Acta. 2010;1803(1):55–71. doi:10.1016/j.bbamcr.2010.01.003.
   PubMed Web of Science ®Google Scholar
• Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta. 2000;1477:267–283.
   PubMed Web of Science ®Google Scholar
• Daum S, Bauer U, Foss HD, et al. Increased expression of mRNA for matrix metalloproteinases-1 and −3 and tissue inhibitor of metalloproteinases-1 in intestinal biopsy specimens from patients with coeliac disease. Gut. 1999;44:17–25.
   PubMed Web of Science ®Google Scholar
• Chu F, Shi M, Zheng C, et al. The roles of macrophages and microglia in multiple sclerosis and experimental autoimmune encephalomyelitis. J Neuroimmunol. 2018;318:1–7. doi:10.1016/j.jneuroim.2018.02.015.
   PubMed Web of Science ®Google Scholar
• Zhang Y, McCluskey K, Fujii K, Larry MW. Differential Regulation of Monocyte Matrix Metalloproteinase and TIMP-1 production by TNF-α, Granulocyte-Macrophage CSF, and IL-1β Through Prostaglandin-Dependent and -Independent Mechanisms. J Immunol. 1998;161(6):3071–3076.
   PubMed Web of Science ®Google Scholar
• Roma-Lavisse C, Tagzirt M, Zawadzki C, et al. M1 and M2 macrophage proteolytic and angiogenic profile analysis in atherosclerotic patients reveals a distinctive profile in type 2 diabetes. Diab Vasc Dis Res. 2015;12(4):279–289. doi:10.1177/1479164115582351.
   PubMed Web of Science ®Google Scholar
• Zajac E, Schweighofer B, Kupriyanova TA, et al. Angiogenic capacity of M1- and M2-polarized macrophages is determined by the levels of TIMP-1 complexed with their secreted proMMP-9. Blood. 2013;122(25):4054–4067. doi:10.1182/blood-2013-05-501494.
   PubMed Web of Science ®Google Scholar
• Bittencourt-Mernak MI, Pinheiro NM, Santana FP, et al. Prophylactic and therapeutic treatment with the flavonone sakuranetin ameliorates LPS-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2017;312(2):L217–l230. doi:10.1152/ajplung.00444.2015.
   PubMed Web of Science ®Google Scholar
• Melton DW, McManus LM, Gelfond JA, Shireman PK. Temporal phenotypic features distinguish polarized macrophages in vitro. Autoimmunity. 2015;48(3):161–176. doi:10.3109/08916934.2015.1027816.
   PubMed Web of Science ®Google Scholar
• Hu VH, Weiss HA, Ramadhani AM, et al. Innate immune responses and modified extracellular matrix regulation characterize bacterial infection and cellular/connective tissue changes in scarring trachoma. Infect Immun. 2012;80(1):121–130. doi:10.1128/IAI.05965-11.
   PubMed Web of Science ®Google Scholar
• Adegunsoye A, Balachandran J. Inflammatory response mechanisms exacerbating hypoxemia in coexistent pulmonary fibrosis and sleep apnea. Mediators Inflamm. 2015;2015:510105. doi:10.1155/2015/125380.
   PubMed Web of Science ®Google Scholar
• Rust R, Blokzijl T, Harms G, et al. TIMP-1 expression in anaplastic large cell lymphoma is usually restricted to macrophages and only seldom observed in tumour cells. J Pathol. 2005;206(4):445–450. doi:10.1002/path.1796.
   PubMed Web of Science ®Google Scholar
• Gold JA, Luchtefeld M, Preuss C, et al. Gp130-dependent release of acute phase proteins is linked to the activation of innate immune signaling pathways. PLoS ONE. 2011;6(5):e19427. doi:10.1371/journal.pone.0019427.
   PubMed Web of Science ®Google Scholar
• Castell JV, Gomez-Lechon MJ, David M, et al. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett. 1989;242:237–239.
   PubMed Web of Science ®Google Scholar
• Zhou D, Huang C, Lin Z, et al. Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways. Cell Signal. 2014;26(2):192–197. doi:10.1016/j.cellsig.2013.11.004.
   PubMed Web of Science ®Google Scholar
• Fang JW, Li JC, Au KY, Yim HCH, Lau ASY. Interleukin-17A differentially modulates BCG induction of cytokine production in human blood macrophages. J Leukoc Biol. 2011;90(2):333–341. doi:10.1189/jlb.0510311.
   PubMed Web of Science ®Google Scholar
• Iredale JP, Benyon RC, Arthur MJ, et al. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology. 1996;24(1):176–184. doi:10.1002/hep.510240129.
   PubMed Web of Science ®Google Scholar
• Lichtinghagen R, Breitenstein K, Arndt B, Kühbacher T, Böker KH. Comparison of matrix metalloproteinase expression in normal and cirrhotic human liver. Virchows Arch. 1998;432:153–158.
   PubMed Web of Science ®Google Scholar
• O’Shea JJ, Plenge R. JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity. 2012;36(4):542–550. doi:10.1016/j.immuni.2012.03.014.
   PubMed Web of Science ®Google Scholar
• Damsky W, King BA. JAK inhibitors in dermatology: the promise of a new drug class. J Am Acad Dermatol. 2017;76(4):736–744. doi:10.1016/j.jaad.2016.12.005.
   PubMed Web of Science ®Google Scholar
• Matrisian LM. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet. 1990;6:121–125.
   PubMed Web of Science ®Google Scholar
• Medina C, Radomski MW. Role of matrix metalloproteinases in intestinal inflammation. J Pharmacol Exp Ther. 2006;318(3):933–938. doi:10.1124/jpet.106.103465.
   PubMed Web of Science ®Google Scholar
• Masciantonio MG, Lee CKS, Arpino V, Mehta S, Gill SE. The balance between metalloproteinases and TIMPs: critical regulator of microvascular endothelial cell function in health and disease. Prog Mol Biol Transl Sci. 2017;147:101–131. doi:10.1016/bs.pmbts.2017.01.001.
   PubMed Web of Science ®Google Scholar
• Parks WC, Wilson CL, Lopez-Boado YS. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol. 2004;4(8):617–629. doi:10.1038/nri1418.
   PubMed Web of Science ®Google Scholar
• Oh WK, Vargas R, Jacobus S, et al. Elevated plasma tissue inhibitor of metalloproteinase-1 levels predict decreased survival in castration-resistant prostate cancer patients. Cancer. 2011;117(3):517–525. doi:10.1002/cncr.25394.
   PubMed Web of Science ®Google Scholar
• Moore CS, Crocker SJ. An alternate perspective on the roles of TIMPs and MMPs in pathology. Am J Pathol. 2012;180(1):12–16. doi:10.1016/j.ajpath.2011.09.008.
   PubMed Web of Science ®Google Scholar
• Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett. 1992;298:29–32.
   PubMed Web of Science ®Google Scholar
• Ries C. Cytokine functions of TIMP-1. Cell Mol Life Sci. 2014;71(4):659–672. doi:10.1007/s00018-013-1457-3.
   PubMed Web of Science ®Google Scholar